Feedback / Questions
Inveltys (loteprednol etabonate nano-suspension 1%) - Kala Pharma
Inveltys: Patent expiry related to MPP technology in 2033
(28th Annual Oppenheimer Healthcare Conference, Kala Pharma)
Mar 22, 2018
Patent
•
Dry Eye Disease • Ophthalmology
https://www.veracast.com/webcasts/opco/healthcare2018/48207276815.cfm?0.399411302329
Mar 22, 2018
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious